News

Refine by category
Refine by year
- 2020
- 2019
- 2018
- Archive

Press Releases —

ADVANZ PHARMA Corp. Announces Results of Special Meeting of Shareholders

17 Dec 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX: ADVZ), a global pharmaceutical company focus
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe

27 Nov 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Third Quarter 2019 Results

07 Nov 2019

Third quarter 2019 revenue of $120 million Third quarter 2019 net loss of $119 million Third quarter 2019
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results

24 Oct 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results

07 Aug 2019

Second quarter 2019 revenue of $131 million Second quarter 2019 net loss of $44 million Second quarter 20
Learn more
Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin

25 Jul 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results

24 Jul 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Industry Related —

Industry Related category item

25 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders

17 Jun 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or the "Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
Investors —

Corporate Presentation

10 Jun 2019

Find here our corporate presentation with information relating to etc ...
Learn more
Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Prochlorperazine

23 May 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), a global pharmaceutical company focuse
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

16 May 2019

First quarter 2019 revenue of $136 million First quarter 2019 net loss of $8 million First quarter 2019 A
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results

14 May 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Press Releases —

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

01 Apr 2019

Company acquires international rights to Salagen® tablets (pilocarpine hydrochloride) (excluding Japan ri
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results

14 Mar 2019

2018 revenue of $537 million, fourth quarter 2018 revenue of $118 million 2018 net income of $1.5 billion
Learn more
Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Fourth Quarter and 2018 Results

21 Feb 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more
Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Supplemental Statement of Objections

30 Jan 2019

ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceuti
Learn more

News

Refine by category

Refine by year

Press Releases —

ADVANZ PHARMA Corp. Announces Results of Special Meeting of Shareholders

Press Releases —

ADVANZ PHARMA Corp. Announces Proposal to Re-domicile from Canada to Europe

Press Releases —

ADVANZ PHARMA Corp. Announces Third Quarter 2019 Results

Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Third Quarter 2019 Results

Press Releases —

ADVANZ PHARMA Corp. Announces Second Quarter 2019 Results

Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Nitrofurantoin

Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Second Quarter 2019 Results

Industry Related —

Industry Related category item

Press Releases —

ADVANZ PHARMA Corp. Announces Results of Annual Meeting of Shareholders

Investors —

Corporate Presentation

Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Statement of Objections Related to Prochlorperazine

Press Releases —

ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for First Quarter 2019 Results

Press Releases —

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

Press Releases —

ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results

Press Releases —

ADVANZ PHARMA Corp. Announces Release Date for Fourth Quarter and 2018 Results

Press Releases —

ADVANZ PHARMA Corp. Comments on CMA Supplemental Statement of Objections

Featured News

Get up-to-date news direct to your inbox.

ADVANZ PHARMA Corp. Acquires International Rights to Two Medicines

Concordia International Corp. Announces Addition of Pharmaceutical Industry Expert to its Board of Directors

ADVANZ PHARMA Corp. Announces Fourth Quarter and Fiscal 2018 Results